Document is current
Any future updates will be listed below
-
Authors
Voskrebenzev, Andreas https://orcid.org/0000-0001-5699-1841
Gutberlet, Marcel
Klimeš, Filip
Behrendt, Lea
Shin, Hoen-oh
Kauczor, Hans-Ulrich
Wacker, Frank
Vogel-Claussen, Jens
Kaireit, Till F.
-
Funding
Funding for this research was provided by:
German Center for Lung Research (82DZLI05A2)
PRACTIS – Clinician Scientist Program of Hannover Medical School (ME 3696/3-1)
- License Information
-
More Information
Article History
Received: 13 November 2025
Revised: 22 January 2026
Accepted: 6 February 2026
First Online: 28 March 2026
Compliance with ethical standards
:
: The scientific guarantor of this publication is Andreas Voskrebenzev.
: F.K., A.V., and J.V.-C. are shareholders of BioVisioneers GmbH, a company, that has an interest in pulmonary magnetic resonance imaging methods.
: One of the authors has significant statistical expertise.
: Written informed consent was obtained from all subjects (patients) in this study.
: All examinations were approved by the central ethics committee in Marburg (Ethics Committee of the Faculty of Medicine, Marburg), as well as by the respective local ethics committees, including the Ethics Committee of Hannover Medical School.
: This study analyzed a subset of 51 participants from the COSYCONET cohort who underwent phase-resolved functional lung (PREFUL) MRI as an additional examination at the Hannover study site. Details of the COSYCONET cohort, including its aims, methodology, and baseline characteristics, are described elsewhere [ ].
:
